ZLD 0.71% 70.0¢ zelira therapeutics limited

Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial, page-16

  1. 2,570 Posts.
    lightbulb Created with Sketch. 482
    From proactive investors

    Zelira Therapeutics and Levin Health talk upcoming chronic pain clinical trialZelira Therapeutics Ltd's (ASX:ZLD) (OTCMKTS:ZLDAF) Dr Oludare Odumosu and Levin Health Limited's Mark Brayshaw discuss plans for its upcoming chronic pain clinical trial. Levin will use Zelira's ZTL-106 formulation for testing on retired athletes in a chronic pain treatment study at La Trobe University in Melbourne. The trial will be sponsored by Levin, which will pay Zelira to design and manage the study, while both companies will share any commercialisation profits.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.